Trametinib targets BRAF V600E/K-mutant melanoma and NSCLC by blocking MEK signaling. You’ll find it as a film-coated tablet in two doses: 0.5 milligrams and 2 milligrams.
The go-to dose is 2 milligrams, taken every day on an empty stomach. The tablets come in bottles with 30 pills in each one.
